Navigation Links
Replidyne to Report First Quarter 2008 Earnings
Date:4/29/2008

most advanced product candidate, faropenem medoxomil, is a novel oral community antibiotic, expected to be appropriate for use as a first-line antibiotic for treatment of respiratory and skin infections in adult and pediatric patients. Replidyne's investigational antibacterial agent REP3123 targets Gram-positive C. difficile bacteria and C. difficile Infection (CDI). Replidyne is pursuing the development of other novel anti-infective programs based on its DNA replication inhibition technology and its in-house discovery research.

Safe Harbor

This press release contains plans, intentions, objectives, estimates and expectations that constitute forward-looking statements about Replidyne, Inc. that involve significant risks and uncertainties. Actual results could differ materially from those discussed due to a number of factors including, the success and timing of pre-clinical studies and clinical trials; the Company's ability to obtain a new partner for faropenem on acceptable terms; the Company's ability to obtain and maintain regulatory approval of product candidates and the labeling under any approval that may be obtained; plans to develop and commercialize product candidates; the loss of key scientific or management personnel; the size and growth of the potential markets for the Company's product candidates and the Company's ability to serve those markets; regulatory developments in the U.S. and foreign countries; the rate and degree of market acceptance of any future products; the accuracy of Company estimates regarding expenses, future revenues and capital requirements; the Company's ability to obtain and maintain intellectual property protection for our product candidates; the successful development of the Company's sales and marketing capabilities; the success of competing drugs that are or become available; and the performance of third party manufacturers. These and additional risks and uncertainties are described more fully in the Company's most
'/>"/>

SOURCE Replidyne, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Replidyne to Announce Third Quarter 2007 Earnings
2. Replidyne to Report 2007 Fourth Quarter and Year-End Earnings
3. Replidyne Announces 2007 Fourth Quarter and Full Year Results
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. QMed, Inc. Reports July Medicare SNP Enrollments
6. Phlo Affiliate Reports Expanded Coverage to Oregon Border
7. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
8. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
9. Carrington Reports Second Quarter 2007 Results
10. Avitar Reports Third Quarter Financial Results for Fiscal 2007
11. Response Genetics Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013  Dr. Gerald ... nucleic acid research, recently launched a new blog in ... Zon ( zon.trilinkbiotech.com ), focuses on what,s trending in ... with industry thought leaders, discussions of research presented at ... Dr. Zon (PhD Princeton University 1971) ...
(Date:5/20/2013)... May 20, 2013 Pacific Biomarkers and Clinigene International ... developers of biosimilars at the 2013 AAPS/ National ... Diego Hotel and Marina , ... the opportunity to speak with company representatives at their ... Cross" on May 21 from 1-2 p.m. in the ...
(Date:5/20/2013)... May 20, 2013 With bed bugs' presence ... that although bed bugs need to be eliminated, one must ... compromise a person's health. And so to help bed bug ... get rid of bed bugs without using harmful ... bug spray it called Bed Bug Bully. , According to ...
(Date:5/20/2013)... BALTIMORE , May 20, 2013 ... regional private-public partnership focusing on commercializing market-relevant biohealth ... Central Maryland , today announced ... the first Entrepreneur-in-Residence (EIR) for BHI at the ... Lung and Blood Institute (NHLBI). Dr. Aiyar ...
Breaking Biology Technology:Dr. Gerald 'Jerry' Zon Launches New Blog for TriLink BioTechnologies 2Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 3BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 4
... ST. LOUIS, June 2 SAFC Hitech(TM), a ... Group (Nasdaq: SIAL ),today announced the introduction ... cost-efficient migration path to controlled precursor delivery,for larger ... combined,with increased safety controls., The OM700 offers ...
... expertise, SAN DIEGO, June 2 Trius ... to its Board of Directors. Truex is,the founder, ... as President and CEO of Peninsula Pharmaceuticals where ... $21000000 from a key,strategic partner) and negotiated both ...
... Further ... Clinical Development of tgAAC94, BOSTON and SEATTLE, May 30 ... release earlier today, entitled,"Targeted Genetics Reports Additional Data From Inflammatory ... study of tgAAC94 in patients with inflammatory arthritis. Pervin,Anklesaria, Ph.D., ...
Cached Biology Technology:SAFC Hitech Introduces Large Scale Bubbler for Compound Semiconductor Production 2SAFC Hitech Introduces Large Scale Bubbler for Compound Semiconductor Production 3Trius Appoints Paul Truex to Board of Directors 2Clarification on Press Release Issued Earlier Today: Targeted Genetics Confirms Positive, Interim Phase 1/2 Study Findings 2Clarification on Press Release Issued Earlier Today: Targeted Genetics Confirms Positive, Interim Phase 1/2 Study Findings 3
(Date:5/16/2013)... creature with ,scissor hand-like, claws in fossil records and ... star. , The 505 million year old fossil ... is a distant ancestor of lobsters and scorpions, was ... role as Edward Scissorhands - a movie about an ... scissors for hands. , Kooteninchela deppi ...
(Date:5/16/2013)... The use of genome-wide analysis (GWA), where the entirety ... the genomic mutations or variants which can cause health ... However, it can also pose major ethical problems ... Society of Human Genetics (ESHG) published on line today ... Human Genetics ., Many services based on whole genome ...
(Date:5/16/2013)... don,t ponder our pulses outside of the gym. But doctors ... heart health. , Zhenan Bao, a professor of chemical engineering ... dollar bill and no wider than a postage stamp. The ... wrist, is sensitive enough to help doctors detect stiff arteries ... used to continuously track heart health and provide doctors a ...
Breaking Biology News(10 mins):Actor Johnny Depp immortalized in ancient fossil find 2European Society of Human Genetics urges caution over use of new genetic sequencing techniques 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 3
... for the annual infectious diseases meeting of the American ... 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) ... Place Convention Center in Chicago, Illinois. ... new information on clinical and basic research in infectious ...
... of a natural body chemical may allow doctors to reduce ... of critically ill patients. "Infection is a common and ... ways to improve the outcomes of sick, elderly patients and, ... Heyland, a professor of Medicine at Queen,s, director of the ...
... the U.S. first responder community,s need for documentary standards ... Institute of Standards and Technology (NIST) Law Enforcement Standards ... to first responders as part of a pilot project ... will help OLES gauge whom needs access to standards ...
Cached Biology News:Finding could reduce antibiotic use in critically ill patients 2It's your standard pilot project: NIST to offer documentary standards to first responders 2
... is a tetramethylrhodamine-conjugated jetSI-ENDO (excitation ... 580 nm), the powerful siRNA ... used to determine the transfection ... delivery and trafficking of siRNAs. ...
... TrackerCumulates a score of movement counts, similar ... it.can track up to 6 subjects at once, ... triggered. Test a whole experimental group at ... the activity. Upgradeable for a variety of ...
... OutputCumulates a score of movement counts, similar to ... track up to 6 subjects at once, in ... Can outpt a sync pulse to coordinate ... use animal location and timing information to control ...
... features of Tracker, plus software to note when ... of the arena, and trigger a penaltyThe Spatial ... built around a video camera, frame grabber, and ... fields at once and up to 6 moving ...
Biology Products: